Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Ustekinumab Levels in Patients With Crohn's Disease: Use in Clinical Practice

NCT05057832 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as lead sponsor.

NCT NCT05057832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05057832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Ustekinumab Levels in Patients With Crohn's Disease: Use in Clinical Practice
Lead sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2021
Completion date
February 1, 2022
Enrollment
95 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease